Table:
begin	end	state
1	20	cytoplasmic
21	43	transmembrane
44	75	non-cytoplasmic
76	95	transmembrane
96	106	cytoplasmic
107	126	transmembrane
127	137	non-cytoplasmic
138	157	transmembrane
158	167	cytoplasmic
168	192	transmembrane
193	209	non-cytoplasmic
210	231	transmembrane
232	257	cytoplasmic
258	284	transmembrane
285	295	non-cytoplasmic
296	317	transmembrane
318	324	cytoplasmic
325	346	transmembrane
347	350	non-cytoplasmic

Input:
>WP_066192693.1 NCBI__GCF_002835735.1:WP_066192693.1
MKKYKSFRLFNEKISFLLYPRAGMILAIMAMVTLSIIVISTGVGEMYIAPLQVLQVFFGQ
GSDLDKLVITDLRLPRILTALFVGMSLAVAGAILQGMIRNPLASPDILGLTGGASVAVVT
FLTIFSDENYSLTVSINWMPVAAFAGAAAVAFIVYVLSWKKGVSTIRLVLIGIGITALMK
ALTTFMILVGPIYRASQVNLWITGSVSAATWQNVFILAPWSIMFILFAFTYSRNINVQGL
GEEVAVGLGSNVQKQRVIMLAISTALVGCAVAFAGGIGFVGLMAPHMARRLVGSNFGALL
PVSALIGAILVLVSDLIGRTLFSPLEIPAGVFTASIGAPYFIYLLLKAKN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server